Jacob Falck Hansen
Mr. Hansen is a Partner at Lundbeckfonden BioCapital. Prior to that, he worked at Novo Nordisk A/S for 15 years, most recently as Head of Corporate Strategy supporting its Executive Management and Board of Directors.
Mr. Hansen has a deep understanding of the pharma industry across all parts of the value chain and many disease areas. He has significant experience with strategy development and execution and has been a trusted advisor to senior leadership in Novo Nordisk.
Mr. Hansen holds an MSc in Biochemistry and a PhD from the University of Copenhagen. He is the author of more than 25 peer-reviewed scientific publications, including several in high-ranking journals such as Nature and Science, and the recipient of three prestigious awards for young researchers, including the Lundbeck Foundation Talent Prize.